Compugen, Ltd. (NASDAQ: CGEN)

Compugen, Ltd. (NASDAQ: CGEN) is a genomics-based drug and diagnostic discovery company focused on becoming a world leader in the discovery and licensing of product candidates to the drug and diagnostic industries under milestone and revenue sharing agreements. The Company’s powerful, proprietary discovery platforms enable the predictive discovery of numerous therapeutic and diagnostic product candidates. Their collboarations include Biosite, Medarex, Inc., Merck & Co., Inc., Ortho-Clinical Diagnostics, Roche, Siemens Healthcare Diagnostics, Inc., and Teva Pharmaceutical Industries. For further information, visit the Company’s web site at www.cgen.com.